The anti-tumor activity of the RIG-1 agonist was impaired in E5-expressing tumors (data not shown), although this effect did not reach statistical significance.
← all excerpts
Human papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway.
1
—
—